Acta Vet. Brno 2011, 80: 263-268

https://doi.org/10.2754/avb201180030263

Determination of an infectious dose of Leptospira for the performance of challenge test in assessing the efficacy of Leptospira vaccines

Jiří Nepeřený, Josef Chumela, Vladimír Vrzal

Bioveta, a.s., Ivanovice na Hané, Czech Republic

References

1. Boutilier P, Carr A, Shulman RL 2003: Leptospirosis in dogs: A serological survey and case series 1996 to 2001. Vet Ther 4: 387-395
2. Český lékopis 01/2002: Vaccinum leptospirosis ad usum veterinarium: 0447
3. European Pharmacopoeia 01/2005: Canine leptospirosis vaccine (inactivated): 0447
4. Greenlee JJ, Bolin CA, Alt DP, Cheville, NF, Andreasen CB 2004: Clinical and pathological comparison of acute leptospirosis in dogs caused by two strains of Leptospira kirschneri serovar grippotyphosa. Am J Vet Res 65: 1100-1107 <https://doi.org/10.2460/ajvr.2004.65.1100>
5. Greenlee JJ, Alt DP, Bolin CA, Zuerner RI, Andreasen CB 2005: Experimental canine leptospirosis caused by Leptospira interrogans serovar pomona and Bratislava. Am J Vet Res 66: 1816-1822 <https://doi.org/10.2460/ajvr.2005.66.1816>
6. Haake DA 2006: Hamster model of leptospirosis. Curr Protoc Microbiol Chapter 12: Unit 12E.2.
7. Klaasen HL, Molkenboer MJ, Vrijenhoek MP, Kaashoek MJ 2003: Duration of immunity in dogs vaccinated against leptospirosis with a bivalent inactivated vaccine. Vet Microbiol 95: 121-132 <https://doi.org/10.1016/S0378-1135(03)00152-4>
8. Koizumi N, Watanabe H 2005: Leptospirosis vaccines: Past, present, and future. J Postgrad Med 51: 210-214
9. Levett PN 2001: Leptospirosis. Clin Microbiol Rev 14: 296-326 <https://doi.org/10.1128/CMR.14.2.296-326.2001>
10. Randall R, Cooper KH 1944: The goolden hamster (Cricetus auratus) as a test animal for the diagnosis of leptospirosis. Science 100: 133-134 <https://doi.org/10.1126/science.100.2589.133>
11. Reed LJ, Muench HA 1938: Simple method of determining fifty percent endpoints. Am J Hyg 27: 494-497
12. Reed NE, Varney WC, Goddard RD, Wyeth PJ 2000: The maintenance of challenge strains used in the potency test for canine leptospira vaccines. Biologicals 28: 25-28 <https://doi.org/10.1006/biol.1999.0235>
13. Roca B 2006: Leptospirosis. Rev Med Univ Navarra 50: 3-6
14. Schreiber P, Martin V, Najbar W, Sanquer A, Gueguen S, Lebreux B 2005: Prevention of a severe disease by a leptospira vaccination with a multivalent vaccine. Revue Méd Vét 156, 8-9: 427-432
15. Schreiber P, Martin V, Najbar W, Sanguer A, Gueguen S, Lebreux B 2005: Prevention of renal infection and urinary shedding in dogs by a leptospira vaccination. Vet Microbiol 108: 113-118 <https://doi.org/10.1016/j.vetmic.2005.03.007>
16. Silva EF, Santos CS, Athanazio DA, Seyffert N, Seixas FK, Cerqueira GM, Fagundes MQ, Brod CS, Reis MG, Dellagostin OA, Ko AI 2008: Characterization of virulence of Leptospira isolates in a hamster model. Vaccine. 26: 3892-3996. <https://doi.org/10.1016/j.vaccine.2008.04.085>
17. Srivastava SK 2006: Prospects of developing leptospiral vaccines for animals. Indian J Med Microbiol 24: 331-336 <https://doi.org/10.4103/0255-0857.29412>
18. Vijayachari P, Sugunan AP, Shriram AN 2008: Leptospirosis: an emerging global public health problem. J Biosci 33: 557-569 <https://doi.org/10.1007/s12038-008-0074-z>
19. Vinetz JM 2001: Leptospirosis. Curr Opin Infect Dis 14: 527-538 <https://doi.org/10.1097/00001432-200110000-00005>
20. Wang Z, Jin L, Wegrzyn A 2007: Leptospirosis vaccines. Microb Cell Fact 6: 39 <https://doi.org/10.1186/1475-2859-6-39>
front cover
  • ISSN 0001-7213 (printed)
  • ISSN 1801-7576 (electronic)

Current issue

Archive